News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
Research News & Stories
In the Media, Patient Education Resource, Research
Siteman Kids is the First Site of Multicenter CAR-T Trial for Autoimmune Diseases
Access to the novel immunotherapy — which “has the potential for cure” — is the latest offering by the national leader in pediatric hematology, oncology, and cell therapies. Siteman Kids at St. Louis Children’s Hospital, along with WashU Medicine, is the first site to test a novel immunotherapy drug for the treatment of autoimmune diseases […]
In the Media, Research
Siteman Cancer Center announces 2026 American Cancer Society-funded pilot projects
WashU Medicine grant recipients will focus on lung and blood cancers Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, is pleased to announce the next cohort of pilot projects funded by the Institutional Research Grant from the American Cancer Society. The three projects are described below. Under the leadership of Jason Weber, PhD, […]
In the Media, Research
New Imaging Approach Reduces Unnecessary Breast Biopsies by Nearly 25%
WashU researchers at Siteman Cancer Center are advancing breast imaging to help patients avoid invasive procedures and improve the screening experience In a new discovery at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, a team of researchers and physicians found that utilizing ultrasound-guided diffuse optical tomography technology can reduce unnecessary breast biopsy rates by nearly […]
In the Media, Research
Inflammatory Immune Cells Predict Survival, Relapse in Multiple Myeloma
New ‘atlas’ of immune cells in bone marrow cancer lays foundation for more reliable prognosis A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma cells of the bone marrow and has no cure. This large immune cell atlas, which includes […]
In the Media, Research
Ratner Receives $9.86 Million Grant To Study Cancers Caused by Retrovirus
Lee Ratner, MD, PhD, the Alan A. and Edith L. Wolff Professor of Oncology at WashU Medicine, has been awarded a five-year, $9.86 million grant from the National Institutes of Health (NIH) to investigate cancers caused by human retroviruses. This NIH Research Program Project Grant, which includes collaborators at The Ohio State University, supports a […]
Research
Nasal Drops Fight Brain Tumors Noninvasively
Nano-sized medicine boosts anti-cancer immune response, eradicates tumors in mice Researchers at Washington University School of Medicine in St. Louis, along with collaborators at Northwestern University, have developed a noninvasive approach to treat one of the most aggressive and deadly brain cancers. Their technology uses precisely engineered structures assembled from nano-size materials to deliver potent […]
Research
Timing May Be Key To Effective Cancer Treatments
When doctors biopsy and treat cancer may be just as important as how they treat it. New research from Erik Herzog, PhD, the Viktor Hamburger Distinguished Professor in biology at Washington University in St. Louis and a research member at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, revealed that when a treatment is given […]
Clinical, In the Media, Research
Connecting Cancer Patients to Tobacco Treatment is Aim of $7.5 Million, WashU-led Trial
Cancer patients who quit smoking live significantly longer than those who don’t The science is clear: Cancer patients who quit smoking fare much better than those who don’t. Quitters respond better to treatment and are less likely to see their disease come back or develop a new cancer, and they have a lower risk of […]
In the Media, Research, Staff/Faculty Update
WashU Researchers at Siteman Honored With NIH Director’s Awards
Three investigators recognized by high-risk, high-reward research program Three WashU researchers at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine have received prestigious and highly competitive awards through the National Institutes of Health (NIH) Director’s High-Risk, High-Reward Research program. The awards support unconventional approaches to major challenges in biomedical and behavioral research. Andrew L. Young, […]
Research
Breast Cancer Startup Founded by WashU Medicine Researchers Acquired by Lunit
Prognosia’s AI-based imaging tech could improve prevention, early detection of breast cancer An innovative biotech startup founded by researchers at Washington University School of Medicine in St. Louis has been acquired by Lunit, a leading company in developing AI-based technologies for cancer prevention and early detection. The WashU startup, Prognosia, was created to develop software […]